Paulo) for kindly providing p24Gag from HIV-1, and Dr. Gabriela Ribeiro-dos-Santos for reviewing the manuscript. References 1. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, et al. (2010) Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362: 2271–2281. 2. UNAIDS (2010) AIDS Epidemic Update. Available: http://www.unaids.org/ globalreport/Global_report.htm. Accessed 2011 Jan 15. 3. John GC, Nduati RW, Mbori-Ngacha DA, Richardson BA, Panteleeff D, et al. (2001) Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 183: 206–212. 4. Becquet R, Bland R, Leroy V, Rollins NC, Ekouevi DK, et al. (2009) Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS One 4: e7397. 5. Lohman-Payne B, Slyker J, Rowland-Jones SL (2010) Immune-based approach- es to the prevention of mother-to-child transmission of HIV-1: active and passive immunization. Clin Perinatol 37: 787–805. 6. Rigato PO, Fusaro AE, Victor JR, Sato MN (2009) Maternal immunization to modulate the development of allergic response and pathogen infections. Immunotherapy 1: 141–156. 7. de Brito CA, Goldoni AL, Sato MN (2009) Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response. Immunotherapy 1: 883–895. 8. Siegrist CA (2007) The challenges of vaccine responses in early life: selected examples. J Comp Pathol 137 Suppl 1: S4–9. 9. Siegrist CA, Barrios C, Martinez X, Brandt C, Berney M, et al. (1998) Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 28: 4138–4148. 10. Manickan E, Yu Z, Rouse BT (1997) DNA immunization of neonates induces immunity despite the presence of maternal antibody. J Clin Invest 100: 2371–2375. 11. Sedegah M, Belmonte M, Epstein JE, Siegrist CA, Weiss WR, et al. (2003) Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J Immunol 171: 3148–3153. 12. Rigato PO, Maciel M, Jr., Goldoni AL, Piubelli O, de Brito CA, et al. (2010) Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood. Virology 406: 37–47. 13. Goldoni AL, Maciel M, Jr., Rigato PO, Piubelli O, de Brito CA, et al. (2011) Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice. Immunobiology 216: 505–512. 14. Marques ET, Jr., Chikhlikar P, de Arruda LB, Leao IC, Lu Y, et al. (2003) HIV- 1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompat- ibility class II compartment, and elicits enhanced immune responses. J Biol Chem 278: 37926–37936. 15. de Arruda LB, Chikhlikar PR, August JT, Marques ET (2004) DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology 112: 126–133. 16. Arruda LB, Sim D, Chikhlikar PR, Maciel M, Jr., Akasaki K, et al. (2006) Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1- HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J Immunol 177: 2265–2275. Maternal and Fetal Priming by DNA Immunization Author Contributions Conceived and designed the experiments: POR MM MNS. Performed the experiments: POR ALG OGP NMO. Analyzed the data: POR MM MNS. Contributed reagents/materials/analysis tools: MM ETM JTA AJSD MNS. Wrote the paper: POR MM MNS. 17. Xin KQ, Sasaki S, Kojima Y, Jounai N, Kumamoto Y, et al. (2002) Detection of Progeny Immune Responses after Intravenous Administration of DNA Vaccine to Pregnant Mice. Biol Proced Online 3: 91–101. 18. Okuda K, Xin KQ, Haruki A, Kawamoto S, Kojima Y, et al. (2001) Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice. J Immunol 167: 5478–5484. 19. Jones EA, Waldmann TA (1972) The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest 51: 2916–2927. 20. Kim J, Mohanty S, Ganesan LP, Hua K, Jarjoura D, et al. (2009) FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J Immunol 182: 2583–2589. 21. de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, et al. (2009) Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun 77: 4383–4395. 22. Bogen B, Dembic Z, Weiss S (1993) Clonal deletion of specific thymocytes by an immunoglobulin idiotype. Embo J 12: 357–363. 23. Victor JR, Muniz BP, Fusaro AE, de Brito CA, Taniguchi EF, et al. (2010) Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells. BMC Immunol 11: 11. 24. Victor JR, Jr., Fusaro AE, Duarte AJ, Sato MN (2003) Preconception maternal immunization to dust mite inhibits the type I hypersensitivity response of offspring. J Allergy Clin Immunol 111: 269–277. 25. Fusaro AE, de Brito CA, Taniguchi EF, Muniz BP, Victor JR, et al. (2009) Balance between early life tolerance and sensitization in allergy: dependence on the timing and intensity of prenatal and postnatal allergen exposure of the mother. Immunology 128: e541–550. 26. Fusaro AE, Brito CA, Victor JR, Rigato PO, Goldoni AL, et al. (2007) Maternal-fetal interaction: preconception immunization in mice prevents neonatal sensitization induced by allergen exposure during pregnancy and breastfeeding. Immunology 122: 107–115. 27. Horwitz DA, Zheng SG, Wang J, Gray JD (2008) Critical role of IL-2 and TGF- beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 38: 912–915. 28. Kanwar B, Favre D, McCune JM (2010) Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS 5: 151–157. 29. Hassett DE, Zhang J, Whitton JL (1997) Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol 71: 7881–7888. 30. Rinaldi M, Signori E, Rosati P, Cannelli G, Parrella P, et al. (2006) Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety. Vaccine 24: 4586–4591. 31. Gerdts V, Babiuk LA, van Drunen Littel-van den H, Griebel PJ (2000) Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 6: 929–932. 32. Xin KQ, Ooki T, Jounai N, Mizukami H, Hamajima K, et al. (2003) A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV. J Gene Med 5: 438–445. 33. Fusaro AE, Maciel M, Victor JR, Oliveira CR, Duarte AJ, et al. (2002) Influence of maternal murine immunization with Dermatophagoides pteronyssinus extract on the type I hypersensitivity response in offspring. Int Arch Allergy Immunol 127: 208–216. PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e31608